Wallach's Interpretation of Diagnostic Tests: Pathways to Arriving at a Clinical Diagnosis (378 page)

BOOK: Wallach's Interpretation of Diagnostic Tests: Pathways to Arriving at a Clinical Diagnosis
3.28Mb size Format: txt, pdf, ePub
   Test no longer recommended: serum immunoelectrophoresis.
Suggested Readings
Bergsagel PL, Mateos M-V, Gutierres NC, et al. Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma.
Blood.
2013;121:884–892.
Kyle RA, Rajkumar SV. Multiple myeloma.
Blood.
2008;111:2962–2972.
MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
   Definition

MGUS is an asymptomatic preneoplastic condition characterized by the presence in the serum of

   Monoclonal (M)-protein, but <3 g/dL
   Bone marrow clonal plasma cells <10%
   No lytic lesions, anemia, hypercalcemia, or renal insufficiency (see below), that is, no end-organ damage that can be attributed to the plasma cell proliferative disorder. A special situation was recently discussed: monoclonal gammopathies associated with kidney disease and the term “monoclonal gammopathy of renal significance” was proposed.
   No clinical manifestations or evidence of another B-cell proliferative disorder.

In most cases, neoplastic plasma cells are present in the bone marrow; however, clonal IgM-producing cells may be seen originating in the spleen and lymph nodes. The risk of progression to an overt plasma cell myeloma, amyloidosis (), lymphoplasmacytic lymphoma , or other lymphoproliferative disorder is 1% per year. MGUS patients with abnormal free light chain ratio are at high risk of developing amyloidosis. MGUS has been divided into three subtypes with different modes of progression: non-IgM MGUS, the most prevalent, IgM-MGUS, and light chain MGUS.

   Who Should Be Suspected?

MGUS is more common in men (1.5:1) and African American subjects; its incidence is 4.2% in individuals older than 50 years and 5% in those older than 70. There are no distinctive symptoms or physical findings associated with this disorder. Seventy-nine percent to 82% of patients with the systemic capillary leak syndrome have MGUS.

   Laboratory Findings
   Bone marrow biopsy and aspirate. Plasma cells are increased, but <10; interstitial and in small cluster distribution.
   CBC is usually normal. Rouleaux formation (due to paraproteinemia) may be seen.
   Serum proteins may be elevated with increased globulins (decreased A:G ratio) and hypoalbuminemia.
   Hypogammaglobulinemia may be present in light chain MGUS where only light chains are produced.

Other books

Whisky State of Mind by Blakemore-Mowle, Karlene
Shiri by D.S.
Heart Strike by M. L. Buchman
Flight by Neil Hetzner
Blue Magic by A.M. Dellamonica
Queen of Someday by Sherry Ficklin
Seeing Off the Johns by Rene S Perez II
Convictions by Julie Morrigan
Silver Shadows by Richelle Mead